Pillar Biosciences, Inc., a leader in oncology-focused next-generation sequencing (NGS) solutions, today announced the launch of the MRDTectâ„¢ NPM1 and FLT3 ITD Panel, a research-use-only (RUO), kitted ...
When reading articles about genetic testing, terms like PCR, Sanger sequencing, NGS, and digital PCR often appear.While all ...
Have you ever come across the term "NGS" in articles about cancer gene panel testing or whole-genome analysis?NGS is a technology that reads DNA base sequences in large quantities.While conventional ...
This partnership is especially relevant to NGS core laboratories and customers who prepare NGS libraries from a high volume ...
Conventional AI works on one token at a time, but a new method speeds this up, called Next-Concept Modeling (NCM). An AI ...
NGS core labs can now run validated automated library prep workflows for SMART-Seq kits on the firefly, with no in-house ...
Kiszala, the CEO and co-founder of intoDNA, to explore how a breakthrough in understanding DNA damage and repair could ...
Target workflow instruments, drug discovery and North America; use competitive, patent and partnership insights to sharpen market positioning and go-to-market strategies.Dublin, Oct. 20, 2026 (GLOBE ...
US genomics technology firm Element Biosciences, backed by Samsung Electronics as its largest shareholder, is kicking off a ...
MassBio is partnering with the ElevateBio team on November 2 to host 2026 R&D Reimagined – Techbio Solutions, the second in a ...
Learn when TIDE-based Sanger sequencing can replace NGS for measuring on-target gene editing efficiency in regulated ...
Global Transcriptomics Market size is expected to be worth around US$ 23.6 Billion by 2034 from US$ 7.4 Billion in 2024.